Mercedes Giralt

Author PubWeight™ 21.69‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Interleukin-6 regulation of AMP-activated protein kinase. Potential role in the systemic response to exercise and prevention of the metabolic syndrome. Diabetes 2006 1.44
2 Retracted Interleukin-6 receptor expression in contracting human skeletal muscle: regulating role of IL-6. FASEB J 2005 1.39
3 Astrocyte-targeted expression of IL-6 protects the CNS against a focal brain injury. Exp Neurol 2003 1.16
4 Metallothionein reduces central nervous system inflammation, neurodegeneration, and cell death following kainic acid-induced epileptic seizures. J Neurosci Res 2005 1.08
5 Astrocyte-specific deficiency of interleukin-6 and its receptor reveal specific roles in survival, body weight and behavior. Brain Behav Immun 2012 1.01
6 Brain response to traumatic brain injury in wild-type and interleukin-6 knockout mice: a microarray analysis. J Neurochem 2005 0.93
7 Astrocyte-targeted expression of interleukin-6 protects the central nervous system during neuroglial degeneration induced by 6-aminonicotinamide. J Neurosci Res 2003 0.91
8 Differential role of tumor necrosis factor receptors in mouse brain inflammatory responses in cryolesion brain injury. J Neurosci Res 2005 0.90
9 Cyclic GMP phosphodiesterase inhibition alters the glial inflammatory response, reduces oxidative stress and cell death and increases angiogenesis following focal brain injury. J Neurochem 2009 0.86
10 Metallothionein-I overexpression decreases brain pathology in transgenic mice with astrocyte-targeted expression of interleukin-6. J Neuropathol Exp Neurol 2003 0.86
11 Diverging mechanisms for TNF-alpha receptors in normal mouse brains and in functional recovery after injury: From gene to behavior. J Neurosci Res 2007 0.85
12 Transgenic mice with astrocyte-targeted production of interleukin-6 are resistant to high-fat diet-induced increases in body weight and body fat. Brain Behav Immun 2009 0.84
13 Specificity and divergence in the neurobiologic effects of different metallothioneins after brain injury. J Neurosci Res 2006 0.83
14 Role of metallothionein-III following central nervous system damage. Neurobiol Dis 2003 0.83
15 Metallothionein 1+2 protect the CNS during neuroglial degeneration induced by 6-aminonicotinamide. J Comp Neurol 2002 0.83
16 Metallothionein prevents neurodegeneration and central nervous system cell death after treatment with gliotoxin 6-aminonicotinamide. J Neurosci Res 2004 0.82
17 Analysis of the cerebral transcriptome in mice subjected to traumatic brain injury: importance of IL-6. Neuroimmunomodulation 2007 0.81
18 Retracted Exercise-induced metallothionein expression in human skeletal muscle fibres. Exp Physiol 2005 0.81
19 Metallothionein-I overexpression alters brain inflammation and stimulates brain repair in transgenic mice with astrocyte-targeted interleukin-6 expression. Glia 2003 0.79
20 Novel roles for metallothionein-I + II (MT-I + II) in defense responses, neurogenesis, and tissue restoration after traumatic brain injury: insights from global gene expression profiling in wild-type and MT-I + II knockout mice. J Neurosci Res 2006 0.78
21 Obesity and metabolomics: metallothioneins protect against high-fat diet-induced consequences in metallothionein knockout mice. OMICS 2015 0.78
22 Expression of metallothionein-I, -II, and -III in Alzheimer disease and animal models of neuroinflammation. Exp Biol Med (Maywood) 2006 0.77
23 The comparison of mouse full metallothionein-1 versus alpha and beta domains and metallothionein-1-to-3 mutation following traumatic brain injury reveals different biological motifs. J Neurosci Res 2010 0.76
24 Catecholaminergic and cholinergic systems of mouse brain are modulated by LMN diet, rich in theobromine, polyphenols and polyunsaturated fatty acids. Food Funct 2015 0.76
25 Metallothionein expression and oxidative stress in the brain. Methods Enzymol 2002 0.75